SCHEMBL8936636

SCHEMBL8936636

CC(S)(CS)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767218 0.80
SCHEMBL6771168 0.80
SCHEMBL4458956 0.76 TP53 (0.31)
SCHEMBL454439 0.74
SCHEMBL4456599 0.74
SCHEMBL6769713 0.72 CYP4F2 (0.33)
SCHEMBL6771879 0.72
Sulfuric Acid SCHEMBL31019639 0.70 CA5A (0.50)
SCHEMBL6771702 0.67
SCHEMBL6766819 0.67 PTGS1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996030299-A1 METHOD OF REGENERATION OF IRON CHELATES IN NITRIC OXIDE SCRUBBING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-10-03 WO claimed
US-5252466-A Hybrids BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION (US) 1993-10-12 US disclosed
EP-0472658-A4 FUSION PROTEINS HAVING AN IN VIVO POST-TRANSLATIONAL MODIFICATION SITE AND METHODS OF MANUFACTURE AND PURIFICATION BIOTECHNOLOGY RES & DEV (US) 1992-08-26 EP disclosed
EP-0472658-A1 FUSION PROTEINS HAVING AN IN VIVO POST-TRANSLATIONAL MODIFICATION SITE AND METHODS OF MANUFACTURE AND PURIFICATION BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION INCORPORATED (US) 1992-03-04 EP disclosed
WO-1990014431-A1 FUSION PROTEINS HAVING AN IN VIVO POST-TRANSLATIONAL MODIFICATION SITE AND METHODS OF MANUFACTURE AND PURIFICATION BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION (US) 1990-11-29 WO disclosed